Search Results 421-430 of 16955 for macronutrient manipulation
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Dr. Welliver leads a multidisciplinary translational research program that integrates tumor genetic biomarkers, imaging-based biomarkers and patient-derived ...
The purpose of this study is to assess the effectiveness of SIC 8000 injected into the submucosa under polyps, adenomas, early-stage cancers or other ...
The Somatic Mutations in Development and Aging Lab of Alexej Abyzov, Ph.D., at Mayo Clinic provides postdoctoral and graduate training, ...
TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...
About this study. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the ...
If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...
The purpose of this study is to see if Resting Energy Expenditure (REE),the amount of energy the body uses when resting, and physical activity will predict ...
The purpose of this study is to evaluate the safety and efficacy of oral Pyridorin 300 mg BID in reducing the rate of progression of nephropathy due to type 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.